Semaglutide (trifluoroacetate salt) 10 mg | ≥95% Cayman Chemical A GLP-1R agonist More Information Supplier Page × Semaglutide (trifluoroacetate salt)
Survodutide (trifluoroacetate salt) 5 mg | ≥98% Cayman Chemical A peptide agonist of GCGR and GLP-1R More Information Supplier Page × Survodutide (trifluoroacetate salt)
Survodutide (trifluoroacetate salt) 25 mg | ≥98% Cayman Chemical A peptide agonist of GCGR and GLP-1R More Information Supplier Page × Survodutide (trifluoroacetate salt)
Survodutide (trifluoroacetate salt) 10 mg | ≥98% Cayman Chemical A peptide agonist of GCGR and GLP-1R More Information Supplier Page × Survodutide (trifluoroacetate salt)
Lepzacitinib 5 mg | ≥98% Cayman Chemical A JAK1 and JAK3 inhibitor More Information Supplier Page × Lepzacitinib
Lepzacitinib 25 mg | ≥98% Cayman Chemical A JAK1 and JAK3 inhibitor More Information Supplier Page × Lepzacitinib
Lepzacitinib 10 mg | ≥98% Cayman Chemical A JAK1 and JAK3 inhibitor More Information Supplier Page × Lepzacitinib
CFT-1946 500 µg | ≥98% Cayman Chemical A degrader of B-RAFV600E, B-RAFG469A, and B-RAFG466V More Information Supplier Page × CFT-1946
Lepzacitinib 1 mg | ≥98% Cayman Chemical A JAK1 and JAK3 inhibitor More Information Supplier Page × Lepzacitinib
CFT-1946 1 mg | ≥98% Cayman Chemical A degrader of B-RAFV600E, B-RAFG469A, and B-RAFG466V More Information Supplier Page × CFT-1946
